| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PATH.4143 |
| P8608 | Fatcat ID | release_qlswzixdmfgubolkaeahufjfki |
| P698 | PubMed publication ID | 23180380 |
| P5875 | ResearchGate publication ID | 233770346 |
| P50 | author | Sara Ricardo | Q53231632 |
| Ana S. Ribeiro | Q55711133 | ||
| Nuno Mendes | Q58177849 | ||
| Ana Rita Nobre | Q59086687 | ||
| Bárbara Sousa | Q37382057 | ||
| André Albergaria | Q37382123 | ||
| Joana Paredes | Q37382149 | ||
| Fernando Schmitt | Q37382197 | ||
| Raquel Seruca | Q37829860 | ||
| Ola Söderberg | Q39977684 | ||
| Manuel Santos | Q42712782 | ||
| P2093 | author name string | Laura Carreto | |
| Rene Gerhard | |||
| Jorge F Cameselle-Teijeiro | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| miR-200 enhances mouse breast cancer cell colonization to form distant metastases | Q21091183 | ||
| The juxtamembrane region of the cadherin cytoplasmic tail supports lateral clustering, adhesive strengthening, and interaction with p120ctn | Q24683225 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| A repeating amino acid motif shared by proteins with diverse cellular roles | Q28237358 | ||
| The novel catenin p120cas binds classical cadherins and induces an unusual morphological phenotype in NIH3T3 fibroblasts | Q28281143 | ||
| Complex networks orchestrate epithelial-mesenchymal transitions | Q29547478 | ||
| Regulation of cadherin-mediated adhesion in morphogenesis | Q29614940 | ||
| Direct observation of individual endogenous protein complexes in situ by proximity ligation | Q29616032 | ||
| TGF-beta and epithelial-to-mesenchymal transitions | Q29616456 | ||
| Cadherin cell adhesion receptors as a morphogenetic regulator | Q29620503 | ||
| p120 catenin regulates the actin cytoskeleton via Rho family GTPases | Q33180846 | ||
| Biophysical properties of cadherin bonds do not predict cell sorting | Q33343541 | ||
| Functional characterization of E- and P-cadherin in invasive breast cancer cells | Q33414412 | ||
| Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype | Q33742129 | ||
| CDH3/P-Cadherin regulates migration of HuCCT1 cholangiocarcinoma cells | Q34389423 | ||
| An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer | Q34433806 | ||
| Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ | Q34459652 | ||
| Cadherins and the tumour progression: is it all in a switch? | Q34502753 | ||
| Similarities between heterophilic and homophilic cadherin adhesion | Q35108263 | ||
| Cell-cell adhesion in the normal ovary and ovarian tumors of epithelial origin; an exception to the rule | Q35138072 | ||
| Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance | Q35142784 | ||
| Rho-regulatory proteins in breast cancer cell motility and invasion | Q35681634 | ||
| p120 catenin is essential for mesenchymal cadherin-mediated regulation of cell motility and invasiveness | Q36118710 | ||
| P-cadherin expression in breast cancer: a review | Q36458759 | ||
| Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers | Q43434952 | ||
| The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma | Q43675665 | ||
| Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands | Q44316967 | ||
| Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone | Q45306974 | ||
| P-cadherin in adhesion and invasion: opposite roles in colon and bladder carcinoma | Q49103182 | ||
| Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. | Q51778849 | ||
| Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. | Q53588886 | ||
| Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival | Q57713449 | ||
| P-cadherin expression in glandular lesions of the uterine cervix detected by liquid-based cytology | Q57713548 | ||
| P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast | Q57713654 | ||
| Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour | Q58966436 | ||
| p120-ctn: A nexus for contextual signaling via Rho GTPases | Q36617587 | ||
| p120-catenin: Past and present | Q36686745 | ||
| P-cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27. | Q37170854 | ||
| Molecular mechanisms controlling E-cadherin expression in breast cancer | Q37238311 | ||
| Hereditary gastric cancer | Q37469480 | ||
| P-cadherin role in normal breast development and cancer | Q37967582 | ||
| Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer | Q38425012 | ||
| PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity | Q38443065 | ||
| P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer. | Q39385880 | ||
| Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer. | Q39745652 | ||
| Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. | Q39776935 | ||
| P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated Snail phosphorylation. | Q39816900 | ||
| Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis | Q39942914 | ||
| P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma | Q40365844 | ||
| P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. | Q40382338 | ||
| Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells | Q40414876 | ||
| P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells | Q40490659 | ||
| E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis | Q41931667 | ||
| P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer | Q42477262 | ||
| Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. | Q42492769 | ||
| Germline E-cadherin mutations in familial lobular breast cancer | Q42566631 | ||
| P433 | issue | 5 | |
| P1104 | number of pages | 14 | |
| P304 | page(s) | 705-718 | |
| P577 | publication date | 2013-01-24 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model | |
| P478 | volume | 229 |
| Q34622433 | Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas |
| Q39185024 | Atomic force microscopy and graph analysis to study the P-cadherin/SFK mechanotransduction signalling in breast cancer cells. |
| Q45347920 | Authors' reply: Combining two antibodies to define E-cadherin loss of expression in non-lobular breast carcinomas: when less is more |
| Q38179961 | Beyond E-cadherin: roles of other cadherin superfamily members in cancer |
| Q38679713 | Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer. |
| Q89357388 | Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma |
| Q48235080 | Cadherins in the retinal pigment epithelium (RPE) revisited: P-cadherin is the highly dominant cadherin expressed in human and mouse RPE in vivo |
| Q26860953 | Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena |
| Q27313331 | Control of cell-cell forces and collective cell dynamics by the intercellular adhesome |
| Q92969736 | E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients |
| Q96640858 | E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements |
| Q37688972 | Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework |
| Q48215330 | Exclusion from spheroid formation identifies loss of essential cell-cell adhesion molecules in colon cancer cells. |
| Q36355885 | Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120) |
| Q92376723 | Gastric Cancer Extracellular Vesicles Tune the Migration and Invasion of Epithelial and Mesenchymal Cells in a Histotype-Dependent Manner |
| Q38216999 | Metastatic breast cancer: mechanisms and opportunities for cytology |
| Q27003394 | P-Cadherin Linking Breast Cancer Stem Cells and Invasion: A Promising Marker to Identify an "Intermediate/Metastable" EMT State |
| Q26781906 | P-cadherin and the journey to cancer metastasis |
| Q37718463 | P-cadherin signals through the laminin receptor α6β4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells. |
| Q50954857 | P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice. |
| Q36567898 | PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance |
| Q92524294 | Prognositic significance of P-cadherin expression in breast cancer: Protocol for a meta-analysis |
| Q36021090 | Prognostic value of a 92-probe signature in breast cancer |
| Q58593670 | SRC inhibition prevents P-cadherin mediated signaling and function in basal-like breast cancer cells |
| Q42516544 | Slug/Pcad pathway controls epithelial cell dynamics in mammary gland and breast carcinoma. |
| Q64253785 | The Crosstalk Between Cell Adhesion and Cancer Metabolism |
| Q34873875 | The bacterial protein azurin impairs invasion and FAK/Src signaling in P-cadherin-overexpressing breast cancer cell models |
| Q34309472 | The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype |
| Q54977960 | The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells. |
| Q38364407 | The role of P-cadherin in skin biology and skin pathology: lessons from the hair follicle |
| Q48299166 | The role of Slit-Robo signaling in the regulation of tissue barriers. |
Search more.